Fig. 3
From: Cost-effectiveness of palivizumab in infants with congenital heart disease: a Swedish perspective

ICER scatter plot from the probabilistic sensitivity analysis
From: Cost-effectiveness of palivizumab in infants with congenital heart disease: a Swedish perspective

ICER scatter plot from the probabilistic sensitivity analysis